Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6680644 | 0.75 | LMNA (0.32) | LMNARAB9A | |
| SCHEMBL7090673 | 0.72 | ADORA3 (0.35) | RAB9A | |
| SCHEMBL6684298 | 0.69 | AGPAT2 (0.38) | RAB9A | |
| SCHEMBL6794232 | 0.68 | FBP1 (0.35) | FBP1 | |
| SCHEMBL21130272 | 0.66 | LMNA (0.43) | LMNAELANERAB9A | |
| SCHEMBL21130274 | 0.64 | LMNA (0.55) | LMNAELANERAB9A | |
| SCHEMBL21130279 | 0.64 | LMNA (0.58) | LMNAELANERAB9A | |
| SCHEMBL6182747 | 0.63 | RARA (0.36) | LMNAELANERAB9A | |
| SCHEMBL7470660 | 0.63 | ELANE (0.35) | LMNAELANERAB9A | |
| SCHEMBL23478802 | 0.62 | ELANE (0.51) | LMNAELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040018941-A1 | Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them | ISHIHARA SANGYO KAISHA, LTD. | 2004-01-29 | — | — | US | disclosed |
| WO-2004008859-A1 | FUSED-BENZENE DERIVATIVES OF THIOURACIL, HERBICIDAL AND DESICCANT COMPOSITIONS CONTANING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018941-A1 | Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them | DDT, DPYD, TST | LMNA 4381/4885ELANE 4038/4885RAB9A 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.